My recovery has been so much easier because Im more active and able to walk more
The FDA classifies semaglutide, tirzepatide, and other GLP-1 receptor agonists as prescription medications because they affect insulin secretion, blood glucose levels, and appetite regulationrequiring medical supervision and periodic monitoring
The results show a clear dose-response relationship: At 4mg weekly, participants in the Phase 2 trial achieved approximately 17.5% mean body weight reduction over 48 weeks
Obesity affects more than 40% of U.S
Such insights are potentially relevant for postGLP1 RA care
Under your doctors guidance, the dose increases in phases from 2 mg to 4 mg, 8 mg, and up to 12 mg per week